-
srdr.ahrq.gov/projects/1671/studies/196102
January 01, 2017 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196107
January 01, 2002 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196117
January 01, 1995 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196123
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196116
January 01, 2009 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196121
January 01, 2001 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196139
January 01, 2011 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196124
January 01, 2000 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196127
January 01, 2003 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196112
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196113
January 01, 1995 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196125
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196136
January 01, 2013 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196110
January 01, 2001 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196115
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196122
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196144
January 01, 1996 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196143
January 01, 2015 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196142
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196147
January 01, 1997 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?